Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Raimundo (Vila Real, Portugal), N. Melo (Porto, Portugal), P. Mota (Porto, Portugal), S. GuimarãEs (Porto, Portugal), C. Souto Moura (Porto, Portugal), R. Cunha (Porto, Portugal), J. Pereira (Porto, Portugal), A. Morais (Porto, Portugal). Factors predicting response to azathioprine in chronic hypersensitivity pneumonitis – the importance of BAL lymphocytosis. 2978

Member's Comments

No comment yet.

Related content which might interest you: The value of lymphocytosis in bronchoalveolar lavage in the differential diagnosis between idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis Source: Annual Congress 2011 - Work, the environment and respiratory disease Year: 2011 Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis Source: ERJ Open Res, 3 (3) 00016-2017; 10.1183/23120541.00016-2017 Year: 2017 Interstitial pneumonia vs. hypersensitivity pneumonitis with autoimmune features Source: International Congress 2017 – ILDs: clinical problems Year: 2017 Prognostic factors in chronic hypersensitivity pneumonitis Source: Eur Respir Rev, 29 (156) 190167; 10.1183/16000617.0167-2019 Year: 2020 Prognostic characteristics in chronic hypersensitivity pneumonitis. Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Markers of treatment outcome in hypersensitivity pneumonitis patients Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases Year: 2016 Induced sputum and BAL from patients with hypersensitivity pneumonitis Source: Eur Respir J 2001; 18: Suppl. 33, 508s Year: 2001 Hypersensitivity pneumonitis associated with the use of temozolomide Source: Eur Respir J 2009; 33: 931-934 Year: 2009 Impact of BAL lymphocytosis and presence of honeycombing on corticosteroid treatment effect in fibrotic hypersensitivity pneumonitis: a retrospective cohort study Source: Eur Respir J, 55 (4) 1901983; 10.1183/13993003.01983-2019 Year: 2020 Impact of lymphocyte differential count in BALF on the mortality of patients with acute exacerbation of idiopathic chronic fibrosing interstitial pneumonia Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Prognostic factors in Korean patients with chronic hypersensitivity pneumonitis Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside Year: 2018 Prevalance and outcomes of pulmonary hypertension in chronic hypersensitivity pneumonitis Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011 Induced sputum in the follow-up of hypersensitivity pneumonitis Source: Eur Respir J 2001; 18: Suppl. 33, 114s Year: 2001 Fibrosis score predicts mortality in patients with chronic hypersensitivity pneumonitis Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Mechanisms of exercise limitation in patients with chronic hypersensitivity pneumonitis Source: ERJ Open Res, 4 (3) 00043-2018; 10.1183/23120541.00043-2018 Year: 2018 Prognostic impact of bronchoalveolar lavage lymphocytosis in patients with chronic Hypersensitivity Pneumonitis Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: risk stratification and management Year: 2018 Factors associated with increased arterial stiffness in patients with chronic hypersensitivity pneumonitis Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new? Year: 2019 Diagnosis and management of chronic fibrotic hypersensitivity pneumonitis Source: Virtual Congress 2020 – Diagnosis and management of chronic fibrotic hypersensitivity pneumonitis Year: 2020 The perpetual enigma of bronchoalveolar lavage fluid lymphocytosis in chronic hypersensitivity pneumonitis: is it of diagnostic value? Source: Eur Respir J, 56 (2) 2001534; 10.1183/13993003.01534-2020 Year: 2020 Leukocyte telomere length and mycophenolate therapy in chronic hypersensitivity pneumonitis Source: Eur Respir J, 57 (3) 2002872; 10.1183/13993003.02872-2020 Year: 2021